US 2022/0118083 A1Published application

Triple live vaccine of canine distemper virus, canine parvovirus and canine infectious hepatitis virus

AssigneeLiaoning Yikang Biological Corporation Limited

InventorsFengyan Li, Xiuwei Shu, Bo Wang, Yiping Wang, Wenyou Luo, Shenglei Chen, Yanxia Liu

Life of this patent

Estimating the term…

Loading patent…

Abstract

The present invention discloses a combination of vaccine strains for treating, preventing, relieving or controlling Canine Distemper, Canine Parvovirus Enteritis and Canine Infectious Hepatitis, comprising: Canine Distemper virus vaccine strain with the microorganism deposition accession number CGMCC No. 19397, Canine Parvovirus vaccine strain with the microorganism deposition accession number CGMCC No. 19398 and Canine Infectious Hepatitis virus vaccine strain with the microorganism deposition accession number CGMCC No. 19396. The three vaccine strains of the combination of vaccine strains are low in toxicity and good in immunogenicity. The present invention further discloses a live vaccine composition using the above-mentioned combination of vaccine strains as immunogen. The vaccine composition is safe and effective.

Claims15

Dependent claims

A combination of vaccine strains for preventing Canine Distemper, Canine Parvovirus Enteritis and Canine Infectious Hepatitis, or a combination of vaccine strains for preventing Canine Distemper and Canine Parvovirus Enteritis, or a combination of vaccine strains for preventing Canine Parvovirus Enteritis and Canine Infectious Hepatitis;

wherein the vaccine strains comprise Canine Distemper virus vaccine strain, Canine Parvovirus vaccine strain and Canine Infectious Hepatitis virus vaccine strain, or the vaccine strains comprise Canine Distemper virus vaccine strain and Canine Parvovirus vaccine strain, or the vaccine strains comprise Canine Parvovirus vaccine strain and Canine Infectious Hepatitis virus vaccine strain;
the Canine Distemper virus vaccine strain is a viral strain with microorganism deposition accession number CGMCC No. 19397;
the Canine Parvovirus vaccine strain is a viral strain with microorganism deposition accession number CGMCC No. 19398;
and
the Canine Infectious Hepatitis virus vaccine strain is a viral strain with microorganism deposition accession number CGMCC No. 19396.

2 more elements

Dependencies are inferred from the claim text.